Formulation and Drug Delivery

UK Prime Minister Visits Team Behind the Vaccines Manufacturing and Innovation Centre

September 24, 2020

UK's Prime Minister visited the site of the country’s VMIC in Oxfordshire, and met the teams working at the forefront of the national COVID-19 response.

Johnson & Johnson Launches Multi-Country Phase III Trial of Janssen’s COVID-19 Vaccine Candidate

September 23, 2020

A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents.

Stevanato Group Partners with Bexson Biomedical on a Wearable Drug Delivery Device

September 22, 2020

The companies will work together to produce a wearable device that can subcutaneously deliver ketamine therapy as a non-opioid pain treatment.

Sanofi and GSK to Provide the EU with 300 Million Doses of its COVID-19 Vaccine Candidate

September 21, 2020

The companies will receive upfront funding from the European Union for the scale-up of manufacturing capabilities at industrial sites in Belgium, Italy, Germany, and France.

Lonza, Humanigen Partner to Expand Manufacturing of Lenzilumab for Potential COVID-19 Therapy

September 18, 2020

The collaboration will expand the manufacturing capacity for lenzilumab, a COVID-19 therapeutic candidate, in advance of a potential Emergency Use Authorization in 2020.

Novavax in COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India

September 18, 2020

The agreement will Increase global manufacturing capacity for Novavax’s vaccine candidate, NVX-CoV2373, to more than two-billion annualized doses when at full capacity in 2021.

Lilly and Amgen in Manufacturing Collaboration for COVID-19 Antibody Therapies

September 18, 2020

The agreement between the two companies will significantly increase global supply capacity for Lilly's potential COVID-19 treatments.

Russia Completes Deals with India, Mexico, and Brazil for Sputnik V

September 17, 2020

The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.

BioNTech to Acquire Novartis GMP Facility for COVID-19 Vaccine Production

September 17, 2020

BioNTech plans to produce up to 250 million doses of its COVID-19 vaccine candidate, BNT162b2, in the first half of 2021.

Valneva Enters into $1.6-Billion Partnership with UK Government for COVID-19 Vaccine

September 16, 2020

Valneva will supply the UK government with an initial 60 million doses of the vaccine in the second half of 2021, if successful, and will provide more doses thereafter.